CYP1A2 and Prader-Willi syndrome: Among the total PWS cohort, extensive metabolizer (EM) activity prevailed across all cytochromes except CYP1A2, which showed greater ultra-rapid metabolizer (UM) status (<i>p</i> < 0.05), especially among UPD.